· Japanese healthcare company, Miraca’s $725 million acquisition of US-based Caris Life Sciences
· First-ever acquisition of a US clinical laboratory testing business by a Japanese company
· Skaddens is currently advising the acquirer on the debt financing for this acquisition from a consortium of Japanese banks worth approximately $600 million